Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Controlling melanoma at local and systemic levels: is a combination of ablative therapy and immunotherapy the way forward?

Almeida JP, Drezek RA, Foster AE.

Immunotherapy. 2014;6(2):109-11. doi: 10.2217/imt.13.158. No abstract available.

2.

Melanoma vaccines.

Perales MA, Wolchok JD.

Cancer Invest. 2002;20(7-8):1012-26. Review.

PMID:
12449735
3.

Immunotherapy of melanoma.

Chapman PB.

Cancer Chemother Biol Response Modif. 2002;20:371-83. Review. No abstract available.

PMID:
12703215
4.

A case report of putative autoimmunity to prostate cancer after immune-mediated rejection of melanoma through a shared tumor antigen.

Gregor P, Huang QD, Gallardo HF, Rasalan TS, Morris MJ.

Clin Genitourin Cancer. 2012 Jun;10(2):126-9. doi: 10.1016/j.clgc.2011.12.002. Epub 2012 Jan 27. No abstract available.

5.

[Immunotherapy for melanoma: how can tolerance be overcome?].

Robert C.

Ann Dermatol Venereol. 2001 Jun-Jul;128(6-7):709-13. Review. French. No abstract available.

PMID:
11460031
6.

Immunotherapy of melanoma.

Smith C, Cerundolo V.

Immunology. 2001 Sep;104(1):1-7. Review. No abstract available.

7.

Self-recognition and tumor response to immunotherapy.

Ernstoff MS.

J Clin Oncol. 2005 Sep 1;23(25):5875-7. Epub 2005 Aug 8. No abstract available.

PMID:
16087939
8.

Immunologic factors in melanoma.

Donawho CK, Kripke ML.

Clin Dermatol. 1992 Jan-Mar;10(1):69-74. Review. No abstract available.

PMID:
1504930
9.

[Immunological aspects of melanoma].

Sjögren H.

Lakartidningen. 1976 Feb 11;73(7):528-30. Swedish. No abstract available.

PMID:
1250045
10.

Strategies for combining chemotherapy and biotherapy in melanoma.

Buzaid AC.

Cancer Control. 2000 Mar-Apr;7(2):185-97. Review. No abstract available.

PMID:
10783824
11.

Investigative studies in the diagnosis and treatment of melanoma.

Seigler HF.

Invest Radiol. 1986 Jul;21(7):596-600.

PMID:
3733389
12.

Review: dendritic cell immunotherapy for melanoma.

Hadzantonis M, O'Neill H.

Cancer Biother Radiopharm. 1999 Feb;14(1):11-22. Review.

PMID:
10850282
13.

[Dendritic cells--a new weapon in therapy of melanoma?].

Enk A.

Hautarzt. 1996 Jun;47(6):488-90. German. No abstract available.

PMID:
8778075
14.

Immunology and immunotherapy of human malignant melanoma.

Bystryn JC.

Dermatol Clin. 1985 Apr;3(2):327-34. Review.

PMID:
2937585
15.

Malignant melanoma-The cradle of anti-neoplastic immunotherapy.

Koller KM, Wang W, Schell TD, Cozza EM, Kokolus KM, Neves RI, Mackley HB, Pameijer C, Leung A, Anderson B, Mallon CA, Robertson G, Drabick JJ.

Crit Rev Oncol Hematol. 2016 Oct;106:25-54. doi: 10.1016/j.critrevonc.2016.04.010. Epub 2016 May 7. Review.

PMID:
27637351
16.

Update on immunotherapy in melanoma.

Green J, Ariyan C.

Surg Oncol Clin N Am. 2015 Apr;24(2):337-46. doi: 10.1016/j.soc.2014.12.010. Epub 2015 Jan 22. Review.

PMID:
25769716
17.

[Immunological aspects in malignant melanoma].

Macher E.

Arch Dermatol Forsch. 1972;244:234-9. German. No abstract available.

PMID:
4675197
18.
19.

Immunotherapy in malignant melanomaa.

Homes EC, Morton DL, Eilber FR, Golub SE, Sulit HL.

Natl Cancer Inst Monogr. 1976 Nov;44:85-6.

PMID:
799763
20.

Immunotherapy for human malignant melanoma.

Kopf AW.

South Med J. 1975 Apr;68(4):495-503.

PMID:
1124416

Supplemental Content

Support Center